Exane Derivatives Abbott Laboratories Transaction History

Exane Derivatives

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$102.07 - $123.37 $95,843 - $115,844	-939 Closed	0 $0
Q1 2022 Apr 22, 2022	SELL	$114.02 - $139.04 $87,681 - $106,921	-769 Reduced 45.02%	939 $111,000
Q4 2021 Jan 28, 2022	BUY	$115.53 - $141.46 $7,162 - $8,770	62 Added 3.77%	1,708 $240,000
Q3 2021 Oct 26, 2021	BUY	$116.66 - $129.06 $162,390 - $179,651	1,392 Added 548.03%	1,646 $194,000
Q2 2021 Jul 28, 2021	BUY	$105.79 - $124.53 $26,870 - $31,630	254 New	254 $29,000
Q1 2021 Apr 30, 2021	SELL	$108.84 - $128.23 $126,798 - $149,387	-1,165 Closed	0 $0
Q4 2020 Jan 27, 2021	SELL	$105.0 - $114.42 $203,805 - $222,089	-1,941 Reduced 62.49%	1,165 $127,000
Q3 2020 Oct 06, 2020	SELL	$91.64 - $111.29 $4,215 - $5,119	-46 Reduced 1.46%	3,106 $338,000
Q2 2020 Jul 10, 2020	BUY	$76.57 - $98.0 $168,607 - $215,796	2,202 Added 231.79%	3,152 $288,000
Q1 2020 Apr 17, 2020	SELL	$62.82 - $91.86 $12,061 - $17,637	-192 Reduced 16.81%	950 $74,000
Q4 2019 Jan 22, 2020	SELL	$78.51 - $87.4 $7,379 - $8,215	-94 Reduced 7.61%	1,142 $99,000
Q3 2019 Oct 15, 2019	BUY	$81.84 - $88.74 $7,038 - $7,631	86 Added 7.48%	1,236 $103,000
Q2 2019 Jul 12, 2019	BUY	$72.88 - $85.0 $83,812 - $97,750	1,150 New	1,150 $0
Q1 2019 Apr 24, 2019	SELL	$66.22 - $80.06 $38,804 - $46,915	-586 Closed	0 $0
Q4 2018 Jan 31, 2019	BUY	$65.56 - $74.27 $38,418 - $43,522	586 New	586 $42,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.